If your company has years worth of rich patient assay data and/or has a line of sight to generating large amounts of assay data, it is in a unique position to leverage that growing trove of omics real-world data (oRWD) in unique and innovative ways to address these challenges. Check out our latest blog to learn more. https://hubs.ly/Q030pbWj0
DNAnexus
Biotechnology Research
Mountain View, CA 18,435 followers
The Precision Health Data Cloud
About us
DNAnexus, the enterprise platform for precision health, is on a mission to accelerate the development, approval and delivery of personalized treatments. Building on 15 years of bioinformatics innovation and genomics expertise, DNAnexus provides the cloud platform that centralizes and enriches multimodal omics data, supports an extensive suite of informatics use cases, and allows secure collaboration across the care continuum. DNAnexus powers a connected ecosystem trusted by the world’s precision health leaders. This flexible ecosystem makes omics and real-world data accessible, actionable, and secure, while unlocking insights that improve patient lives. For more information, visit www.dnanexus.com or follow @DNAnexus on social media.
- Website
-
http://dnanexus.com
External link for DNAnexus
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Mountain View, CA
- Type
- Privately Held
- Founded
- 2009
- Specialties
- Data management, Computational biology, Bioinformatics, Cloud computing, Clinical-grade security, Electronic Health Records, Multimodal data, Population health, and Precision Health
Locations
-
Primary
Get directions
1975 W El Camino
Suite 101
Mountain View, CA 94040, US
Employees at DNAnexus
-
Dr. Manu Kumar 👋🏽
Chief Firestarter @ K9Ventures • Co-founder @ Carta • Co-founder & CEO @ HiHello • Investor in Lyft, Twilio, Auth0, Carta, LucidChart, Everlaw, &…
-
Nat Goldhaber
Claremont Creek Ventures
-
Serafim Batzoglou
-
Harsh P.
Managing Partner & Co-Founder at Wireframe Ventures
Updates
-
We’re ending 2024 with some great news! We’re honored to receive the 2024 Global Enabling Technology Leadership Award from Frost & Sullivan. We’d like to thank all of the hard work from our employees & partners who have enabled the DNAnexus Platform to become the leading enterprise platform for precision health! https://hubs.ly/Q0302rBZ0
-
-
DNAnexus reposted this
Our experts find that DNAnexus incorporates customer-centric strategies, building strong brand equity and elevating its leadership status in bioinformatics-based technology. ⚕️✨ Discover their Best Practices! Click here: https://lnkd.in/gCMqF47R #FrostAwards #EnablingTechnology
DNAnexus Recognized by Frost & Sullivan for Ability to Integrate and Synchronize Diverse Clinical and Multi-omics Data
prnewswire.com
-
Watch this on-demand webinar to discover how cutting-edge genetic insights are reshaping healthcare: https://hubs.ly/Q02_-S2k0
-
-
#ICYMI Our very own Ben Busby is getting to the bottom of the current genome informatics landscape and the use of generative AI in the latest episode of the Mendelspod podcast available here: https://hubs.ly/Q02_vnCh0
-
-
DNAnexus and Panomics are teaming up to bring comprehensive, interactive multi-omics data solutions to the table. Learn more here: https://hubs.ly/Q02_0Trk0 #BiopharmaInnovation #DataSolutions #MultiOmics
-
-
In our fireside chat series, Mark Effingham discusses the importance of democratizing access to the UK Biobank dataset to their global research community. Read more about their groundbreaking work in our blog announcing their milestone release of whole genome sequencing data from 500,000 participants. (https://hubs.ly/Q02ZhyTS0)
From Code to Cure: Latest UK Biobank Release of Whole Genome Sequence Data from 500,000 Participants Launches New Era in Medical Research
blog.dnanexus.com
-
Join us and NVIDIA this Thursday for an exclusive webinar on MONAI Imaging! Discover how cutting-edge AI is transforming healthcare and enhancing diagnostic accuracy. Register here: https://hubs.ly/Q02-bdpM0
Using Open Source Tools for Deep Learning in Imaging Research
-
Happening in an hour: hear how researchers can pinpoint molecular mechanisms underlying specific conditions by analyzing genetic variations linked to diseases, leading to the development of targeted drugs with higher success rates. https://hubs.ly/Q02Z_6jN0
-